Skip to main content
Clinical Trials/NCT01412788
NCT01412788UnknownPhase 3

Randomized Controlled Trial of Safety and Aesthetic Outcomes of Breast-conserving Surgery With the Peri-areolar Incision Approach

Peking Union Medical College Hospital1 site in 1 country100 target enrollmentStarted: January 1, 2007Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 3
Enrollment
100
Locations
1
Primary Endpoint
event free survival

Study Overview

Brief Summary

Cosmetic result after breast-conserving surgery (BCS) would impose great effect upon patient's quality of life. Although peri-areolar incision has been widely used in benign breast tumor excision, mastopexy procedures and skin-sparing mastectomy with primary reconstruction, the actual safety and aesthetic outcome of the peri-areolar incision approach in BCS for cancer patients has not been established by randomized, controlled trials.

This trial was design to compare the Safety and aesthetic outcomes of breast conserving surgery between peri-areolar incision approach and traditional methods.

Detailed Description

The Trial aims to determine whether BCS with the peri-areolar approach: 1) is safe in terms of the rates of recurrence and metastasis; 2) can improve the post-operative aesthetic score and QOL score.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 60 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •patients desire for breast conserving surgery;
  • •fulfills criteria for breast conserving surgery;
  • •the maximum diameter of the tumor should be less than the semi-perimeter of the areola and that the proximal margin of tumor should be at least 1 cm away from the areola;
  • •patients suitable to receive BCS with either the peri-areolar incision or the traditional incision were included;

Exclusion Criteria

  • •patients not suitable for breast conserving surgery;
  • •skin or sub-cutaneous tumor invasion as definite contra-indication of skin-sparing;
  • •male or bilateral breast cancers who might bring up bias in deciding aesthetic outcomes and expenditure;
  • •Patients who were supposed to benefit from a certain kind of incision were also excluded at the researcher's discretion.

Arms & Interventions

traditional incision

Active Comparator

traditional incision above tumor was used to carry out lumpectomy

Intervention: traditional incision (Procedure)

peri-areolar incision

Experimental

Peri-areolar incision was used to carry out lumpectomy

Intervention: peri-areolar incision (Procedure)

Outcomes

Primary Outcomes

event free survival

Time Frame: 5 years

local recurrence, regional recurrence, distant metastasis, death

Secondary Outcomes

  • cost(2 weeks)
  • aesthetic outcomes(two weeks, half a year and one year)

Investigators

Sponsor Class
Other

Study Sites (1)

Loading locations...

Similar Trials